Quantum-Si Acquires Majelac Technologies to Strengthen Chip Supply Chain
November 09 2021 - 8:00AM
Business Wire
Acquisition expands Quantum-Si’s capabilities
in semiconductor chip assembly and packaging
Quantum-Si Incorporated (NASDAQ: QSI) (“Quantum-Si,” “QSI” or
the “Company”), a life sciences tools company commercializing a
unique single molecule protein sequencing platform, today announced
that it acquired Majelac Technologies LLC, a privately-owned
company providing semiconductor packaging and integrated circuit
assembly services. The acquisition secures best-in-class
semiconductor chip assembly and packaging capabilities for
Quantum-Si in order to secure its supply chain and support scaling
commercialization efforts.
“The acquisition of Majelac brings chip assembly and packaging
capabilities in-house, and it also accelerates our ability to scale
up operations to meet demand and support future chip designs,” said
John Stark, Chief Executive Officer of Quantum-Si. “This strategic
acquisition and vertical integration allow us to secure our supply
chain to meet customer demand amidst existing global semiconductor
supply chain issues.”
“Since its founding in 2002, Majelac began with a simple goal in
mind: to offer a higher caliber of quick-turn integrated circuit
assembly services to the semiconductor industry,” said Michael
Quinn, Founder and President of Majelac. “We are excited to bring
our technical expertise and capabilities to Quantum-Si and support
the Company’s goal to digitize and scale proteomics research.”
“We have worked directly with the Majelac team for several years
and have always admired their high quality and speed,” said Matt
Dyer, Chief Business Officer of Quantum-Si. “We are pleased to
welcome the entire Majelac team who are joining Quantum-Si in our
mission to transform single molecule analysis and democratize
access to the proteome.”
About Quantum-Si
Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focused
on revolutionizing the growing field of proteomics. The Company's
suite of technologies is powered by a first-of-its-kind
semiconductor chip designed to enable single molecule
next-generation protein sequencing and digitize proteomic research
in order to advance drug discovery and diagnostics beyond what has
been possible with DNA sequencing.
Forward-Looking Statements
This press release includes "forward-looking statements" within
the meaning of the "safe harbor" provisions of the United States
Private Securities Litigation Reform Act of 1995. The Company’s
actual results may differ from its expectations, estimates, and
projections and, consequently, you should not rely on these
forward-looking statements as predictions of future events. Words
such as "expect," "estimate," "project," "budget," "forecast,"
"anticipate," "intend," "plan," "may," "will," "could," "should,"
"believes," "predicts," "potential," "continue," and similar
expressions (or the negative versions of such words or expressions)
are intended to identify such forward-looking statements. These
forward looking statements include, without limitation, the
Company’s expectations with respect to future performance and
development of products and services; the Company’s other strategic
plans for its business; the use of the Company’s technology to
expand life sciences markets, the understanding of molecular
changes that cause disease, and the development of new biomarkers;
and the demand for its products. These forward-looking statements
involve significant risks and uncertainties that could cause the
actual results to differ materially from those discussed in the
forward-looking statements. Most of these factors are outside the
Company's control and are difficult to predict. Factors that may
cause such differences include, but are not limited to: the impact
of COVID-19 on the Company's business; the inability to maintain
the listing of the Company's shares of Class A common stock on The
Nasdaq Stock Market; the ability to recognize the anticipated
benefits of the recently completed business combination, which may
be affected by, among other things, competition and the ability of
the Company to grow and manage growth profitably and retain its key
employees; changes in applicable laws or regulations; the ability
of the Company to raise financing in the future; the success, cost
and timing of the Company's product development activities; the
potential attributes and benefits of the Company's products and
services; the Company's ability to obtain and maintain regulatory
approval for its products, and any related restrictions and
limitations of any approved product; the Company's ability to
identify, in-license or acquire additional technology; the
Company's ability to maintain its existing lease, license,
manufacture and supply agreements; the Company's ability to compete
with other companies currently marketing or engaged in the
development of products and services that the Company is
developing; the size and growth potential of the markets for the
Company's future products and services, and its ability to serve
those markets, either alone or in partnership with others; the
pricing of the Company's products and services following
anticipated commercial launch; the Company's estimates regarding
future expenses, future revenue, capital requirements and needs for
additional financing; the Company's financial performance; and
other risks and uncertainties indicated from time to time in the
Company’s Quarterly Report on Form 10-Q for the quarter ended June
30, 2021, including those under "Risk Factors" therein, and in the
Company's other filings with the SEC. The Company cautions that the
foregoing list of factors is not exclusive. The Company cautions
readers not to place undue reliance upon any forward-looking
statements, which speak only as of the date made. The Company does
not undertake or accept any obligation or undertaking to release
publicly any updates or revisions to any forward-looking statements
to reflect any change in its expectations or any change in events,
conditions, or circumstances on which any such statement is
based.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211109005671/en/
Investor Contacts Juan Avendano Vice President, Investor
Relations javendano@quantum-si.com
Mike Cavanaugh ICR Westwicke (617) 877-9641
ir@quantum-si.com
Media Contact Cammy Duong ICR Westwicke (203) 682-8380
QSI-PR@westwicke.com
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Jul 2024 to Aug 2024
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Aug 2023 to Aug 2024